Clinical Trial Update: Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 long-term follow-up of OZ1 gene therapy in HIV-1 patients has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• OZ1 (anti-HIV-1 ribozyme OZ1)

Snippet

Sponsor: Janssen-Cilag Pty Ltd | Conditions: HIV-1 | Phase 2 | Status: COMPLETED | Results posted: 2018-12-12